CAMBRIDGE, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Korro, Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company developing a new class of genetic medicines based on editing RNA for rare and ...
American Society of Gene and Cell Therapy 29th Annual Meeting (ASGCT) TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Conference 3rd International Conference on Ureagenesis Defects and Allied ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
LEXINGTON, Mass.--(BUSINESS WIRE)--TRIANA Biomedicines, Inc. (TRIANA), a leading biopharmaceutical company focused on advancing a target-first and proximity-first molecular glue discovery platform to ...
TRIANA Biomedicines Announces Oral Presentation of TRI-611 and Additional Poster Presentations at the American Association for Cancer Research Annual Meeting 2026 TRIANA Biomedicines, Inc. (TRIANA), a ...
Poster Presentations featuring the latest advancements on anti-TROP2 (OBI 902) and Nectin-4 (OBI 904) ADCs, anti-TROP2/HER2 BsADC (OBI 201), anti-cMET/HER3Bs-Dual ...
(MENAFN- GlobeNewsWire - Nasdaq) BOSTON, April 14, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal ...
The College of Engineering and Applied Sciences invites you to participate in the 2026 Research Week Poster Session. This event will showcase and celebrate the outstanding work of CEAS undergraduate, ...
LA JOLLA, Calif., April 08, 2026 (GLOBE NEWSWIRE)-- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today ...
CAMBRIDGE, Mass., April 06, 2026 (GLOBE NEWSWIRE)-- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for ...
On March 30, 2026, SeaStar Medical Holding Corp. (NASDAQ: ICU) announced two poster presentations at the 31 st International Conference on Advances in Critical Care Nephrology (AKI & CRRT) 2026. The ...
KING OF PRUSSIA, Pa., March 30, 2026 (GLOBE NEWSWIRE) -- SEED Therapeutics, Inc. (“SEED”) , a clinical-stage biotechnology company specializing in molecular glue degraders, today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results